Global and China End-Stage Kidney Disease Treatment Market Insights, Forecast to 2026

Global and China End-Stage Kidney Disease Treatment Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 End-Stage Kidney Disease Treatment Product Introduction
1.2 Market Segments
1.3 Key End-Stage Kidney Disease Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type
1.4.2 MK-3866
1.4.3 Pacritinib
1.4.4 Sanguinate
1.4.5 Tesidolumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global End-Stage Kidney Disease Treatment Market Size, Estimates and Forecasts
2.1.1 Global End-Stage Kidney Disease Treatment Revenue 2015-2026
2.1.2 Global End-Stage Kidney Disease Treatment Sales 2015-2026
2.2 Global End-Stage Kidney Disease Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 End-Stage Kidney Disease Treatment Historical Market Size by Region (2015-2020)
2.3.1 Global End-Stage Kidney Disease Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global End-Stage Kidney Disease Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 End-Stage Kidney Disease Treatment Market Estimates and Projections by Region (2021-2026)
2.4.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Region (2021-2026)
2.4.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Region (2021-2026)
3 Global End-Stage Kidney Disease Treatment Competitor Landscape by Players
3.1 Global Top End-Stage Kidney Disease Treatment Sales by Manufacturers
3.1.1 Global End-Stage Kidney Disease Treatment Sales by Manufacturers (2015-2020)
3.1.2 Global End-Stage Kidney Disease Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Global End-Stage Kidney Disease Treatment Manufacturers by Revenue
3.2.1 Global End-Stage Kidney Disease Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Global End-Stage Kidney Disease Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global End-Stage Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by End-Stage Kidney Disease Treatment Revenue in 2019
3.2.5 Global End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global End-Stage Kidney Disease Treatment Price by Manufacturers
3.4 Global End-Stage Kidney Disease Treatment Manufacturing Base Distribution, Product Types
3.4.1 End-Stage Kidney Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers End-Stage Kidney Disease Treatment Product Type
3.4.3 Date of International Manufacturers Enter into End-Stage Kidney Disease Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global End-Stage Kidney Disease Treatment Market Size by Type (2015-2020)
4.1.1 Global End-Stage Kidney Disease Treatment Sales by Type (2015-2020)
4.1.2 Global End-Stage Kidney Disease Treatment Revenue by Type (2015-2020)
4.1.3 End-Stage Kidney Disease Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global End-Stage Kidney Disease Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Type (2021-2026)
4.2.3 End-Stage Kidney Disease Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global End-Stage Kidney Disease Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global End-Stage Kidney Disease Treatment Market Size by Application (2015-2020)
5.1.1 Global End-Stage Kidney Disease Treatment Sales by Application (2015-2020)
5.1.2 Global End-Stage Kidney Disease Treatment Revenue by Application (2015-2020)
5.1.3 End-Stage Kidney Disease Treatment Price by Application (2015-2020)
5.2 End-Stage Kidney Disease Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global End-Stage Kidney Disease Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global End-Stage Kidney Disease Treatment Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
6.1.1 China End-Stage Kidney Disease Treatment Sales YoY Growth 2015-2026
6.1.2 China End-Stage Kidney Disease Treatment Revenue YoY Growth 2015-2026
6.1.3 China End-Stage Kidney Disease Treatment Market Share in Global Market 2015-2026
6.2 China End-Stage Kidney Disease Treatment Market Size by Players (International and Local Players)
6.2.1 China Top End-Stage Kidney Disease Treatment Players by Sales (2015-2020)
6.2.2 China Top End-Stage Kidney Disease Treatment Players by Revenue (2015-2020)
6.3 China End-Stage Kidney Disease Treatment Historic Market Review by Type (2015-2020)
6.3.1 China End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
6.3.2 China End-Stage Kidney Disease Treatment Revenue Market Share by Type (2015-2020)
6.3.3 China End-Stage Kidney Disease Treatment Price by Type (2015-2020)
6.4 China End-Stage Kidney Disease Treatment Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China End-Stage Kidney Disease Treatment Sales Forecast by Type (2021-2026)
6.4.2 China End-Stage Kidney Disease Treatment Revenue Forecast by Type (2021-2026)
6.4.3 China End-Stage Kidney Disease Treatment Price Forecast by Type (2021-2026)
6.5 China End-Stage Kidney Disease Treatment Historic Market Review by Application (2015-2020)
6.5.1 China End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
6.5.2 China End-Stage Kidney Disease Treatment Revenue Market Share by Application (2015-2020)
6.5.3 China End-Stage Kidney Disease Treatment Price by Application (2015-2020)
6.6 China End-Stage Kidney Disease Treatment Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China End-Stage Kidney Disease Treatment Sales Forecast by Application (2021-2026)
6.6.2 China End-Stage Kidney Disease Treatment Revenue Forecast by Application (2021-2026)
6.6.3 China End-Stage Kidney Disease Treatment Price Forecast by Application (2021-2026)
7 North America
7.1 North America End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
7.2 North America End-Stage Kidney Disease Treatment Market Facts & Figures by Country
7.2.1 North America End-Stage Kidney Disease Treatment Sales by Country (2015-2020)
7.2.2 North America End-Stage Kidney Disease Treatment Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
8.2 Europe End-Stage Kidney Disease Treatment Market Facts & Figures by Country
8.2.1 Europe End-Stage Kidney Disease Treatment Sales by Country
8.2.2 Europe End-Stage Kidney Disease Treatment Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
9.2 Asia Pacific End-Stage Kidney Disease Treatment Market Facts & Figures by Country
9.2.1 Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2015-2020)
9.2.2 Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
10.2 Latin America End-Stage Kidney Disease Treatment Market Facts & Figures by Country
10.2.1 Latin America End-Stage Kidney Disease Treatment Sales by Country
10.2.2 Latin America End-Stage Kidney Disease Treatment Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa End-Stage Kidney Disease Treatment Market Size YoY Growth 2015-2026
11.2 Middle East and Africa End-Stage Kidney Disease Treatment Market Facts & Figures by Country
11.2.1 Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country
11.2.2 Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 BLR Bio LLC
12.1.1 BLR Bio LLC Corporation Information
12.1.2 BLR Bio LLC Description and Business Overview
12.1.3 BLR Bio LLC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Products Offered
12.1.5 BLR Bio LLC Recent Development
12.2 CTI BioPharma Corp
12.2.1 CTI BioPharma Corp Corporation Information
12.2.2 CTI BioPharma Corp Description and Business Overview
12.2.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CTI BioPharma Corp End-Stage Kidney Disease Treatment Products Offered
12.2.5 CTI BioPharma Corp Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 F. Hoffmann-La Roche Ltd Corporation Information
12.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
12.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
12.3.4 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Products Offered
12.3.5 F. Hoffmann-La Roche Ltd Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG End-Stage Kidney Disease Treatment Products Offered
12.4.5 Novartis AG Recent Development
12.5 Prolong Pharmaceuticals LLC
12.5.1 Prolong Pharmaceuticals LLC Corporation Information
12.5.2 Prolong Pharmaceuticals LLC Description and Business Overview
12.5.3 Prolong Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Products Offered
12.5.5 Prolong Pharmaceuticals LLC Recent Development
12.6 VESSL Therapeutics Ltd
12.6.1 VESSL Therapeutics Ltd Corporation Information
12.6.2 VESSL Therapeutics Ltd Description and Business Overview
12.6.3 VESSL Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
12.6.4 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Products Offered
12.6.5 VESSL Therapeutics Ltd Recent Development
12.11 BLR Bio LLC
12.11.1 BLR Bio LLC Corporation Information
12.11.2 BLR Bio LLC Description and Business Overview
12.11.3 BLR Bio LLC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 BLR Bio LLC End-Stage Kidney Disease Treatment Products Offered
12.11.5 BLR Bio LLC Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key End-Stage Kidney Disease Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 End-Stage Kidney Disease Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. End-Stage Kidney Disease Treatment Market Segments
Table 2. Ranking of Global Top End-Stage Kidney Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of MK-3866
Table 5. Major Manufacturers of Pacritinib
Table 6. Major Manufacturers of Sanguinate
Table 7. Major Manufacturers of Tesidolumab
Table 8. Major Manufacturers of Others
Table 9. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global End-Stage Kidney Disease Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global End-Stage Kidney Disease Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global End-Stage Kidney Disease Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global End-Stage Kidney Disease Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global End-Stage Kidney Disease Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global End-Stage Kidney Disease Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global End-Stage Kidney Disease Treatment Sales Share by Manufacturers (2015-2020)
Table 17. Global End-Stage Kidney Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global End-Stage Kidney Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Kidney Disease Treatment as of 2019)
Table 19. End-Stage Kidney Disease Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. End-Stage Kidney Disease Treatment Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers End-Stage Kidney Disease Treatment Price (2015-2020) (USD/Pcs)
Table 22. End-Stage Kidney Disease Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers End-Stage Kidney Disease Treatment Product Type
Table 24. Date of International Manufacturers Enter into End-Stage Kidney Disease Treatment Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 27. Global End-Stage Kidney Disease Treatment Sales Share by Type (2015-2020)
Table 28. Global End-Stage Kidney Disease Treatment Revenue by Type (2015-2020) (US$ Million)
Table 29. Global End-Stage Kidney Disease Treatment Revenue Share by Type (2015-2020)
Table 30. End-Stage Kidney Disease Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global End-Stage Kidney Disease Treatment Sales Share by Type (2021-2026)
Table 32. Global End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 33. Global End-Stage Kidney Disease Treatment Sales Share by Application (2015-2020)
Table 34. Global End-Stage Kidney Disease Treatment Sales Share by Application (2021-2026)
Table 35. Global End-Stage Kidney Disease Treatment Sales Market Share Forecast by Application (2021-2026)
Table 36. Global End-Stage Kidney Disease Treatment Revenue by Application (2015-2020) (US$ Million)
Table 37. Global End-Stage Kidney Disease Treatment Revenue Market Share Forecast by Application (2021-2026)
Table 38. China End-Stage Kidney Disease Treatment Sales (K Pcs) of Key Companies (2015-2020)
Table 39. China End-Stage Kidney Disease Treatment Sales Share by Company (2015-2020)
Table 40. China End-Stage Kidney Disease Treatment Revenue (US$ Million) by Company (2015-2020)
Table 41. China End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2015-2020)
Table 42. China End-Stage Kidney Disease Treatment Sales Share by Type (2015-2020)
Table 43. China End-Stage Kidney Disease Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China End-Stage Kidney Disease Treatment Price (K Pcs) by Type (2015-2020)
Table 45. China End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2021-2026)
Table 46. China End-Stage Kidney Disease Treatment Sales Share by Type (2021-2026)
Table 47. China End-Stage Kidney Disease Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China End-Stage Kidney Disease Treatment Revenue Share by Type (2021-2026)
Table 49. China End-Stage Kidney Disease Treatment Price (K Pcs) by Type (2021-2026)
Table 50. China End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2015-2020)
Table 51. China End-Stage Kidney Disease Treatment Sales Share by Application (2015-2020)
Table 52. China End-Stage Kidney Disease Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2021-2026)
Table 54. China End-Stage Kidney Disease Treatment Sales Share by Application (2021-2026)
Table 55. China End-Stage Kidney Disease Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China End-Stage Kidney Disease Treatment Revenue Share by Application (2021-2026)
Table 57. North America End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 58. North America End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 59. North America End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 60. North America End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 61. Europe End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 62. Europe End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 63. Europe End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Region (2015-2020)
Table 69. Latin America End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Country (2015-2020)
Table 77. BLR Bio LLC Corporation Information
Table 78. BLR Bio LLC Description and Business Overview
Table 79. BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. BLR Bio LLC End-Stage Kidney Disease Treatment Product
Table 81. BLR Bio LLC Recent Development
Table 82. CTI BioPharma Corp Corporation Information
Table 83. CTI BioPharma Corp Description and Business Overview
Table 84. CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. CTI BioPharma Corp Product
Table 86. CTI BioPharma Corp Recent Development
Table 87. F. Hoffmann-La Roche Ltd Corporation Information
Table 88. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 89. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. F. Hoffmann-La Roche Ltd Product
Table 91. F. Hoffmann-La Roche Ltd Recent Development
Table 92. Novartis AG Corporation Information
Table 93. Novartis AG Description and Business Overview
Table 94. Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Novartis AG Product
Table 96. Novartis AG Recent Development
Table 97. Prolong Pharmaceuticals LLC Corporation Information
Table 98. Prolong Pharmaceuticals LLC Description and Business Overview
Table 99. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Prolong Pharmaceuticals LLC Product
Table 101. Prolong Pharmaceuticals LLC Recent Development
Table 102. VESSL Therapeutics Ltd Corporation Information
Table 103. VESSL Therapeutics Ltd Description and Business Overview
Table 104. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. VESSL Therapeutics Ltd Product
Table 106. VESSL Therapeutics Ltd Recent Development
Table 107. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 108. Key Challenges
Table 109. Market Risks
Table 110. Main Points Interviewed from Key End-Stage Kidney Disease Treatment Players
Table 111. End-Stage Kidney Disease Treatment Customers List
Table 112. End-Stage Kidney Disease Treatment Distributors List
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Kidney Disease Treatment Product Picture
Figure 2. Global End-Stage Kidney Disease Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. MK-3866 Product Picture
Figure 4. Pacritinib Product Picture
Figure 5. Sanguinate Product Picture
Figure 6. Tesidolumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. End-Stage Kidney Disease Treatment Report Years Considered
Figure 13. Global End-Stage Kidney Disease Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global End-Stage Kidney Disease Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global End-Stage Kidney Disease Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global End-Stage Kidney Disease Treatment Sales Market Share by Region in 2019
Figure 18. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region in 2019
Figure 20. Global End-Stage Kidney Disease Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by End-Stage Kidney Disease Treatment Revenue in 2019
Figure 22. End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global End-Stage Kidney Disease Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global End-Stage Kidney Disease Treatment Sales Market Share by Type in 2019
Figure 25. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type in 2019
Figure 27. Global End-Stage Kidney Disease Treatment Market Share by Price Range (2015-2020)
Figure 28. Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2019
Figure 30. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application in 2019
Figure 32. China End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2026 (K Pcs)
Figure 33. China End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. China End-Stage Kidney Disease Treatment Market Share in Global Market 2015-2026
Figure 35. China 5 and 10 Largest End-Stage Kidney Disease Treatment Players Market Share by Revenue in End-Stage Kidney Disease Treatment in 2019
Figure 36. China End-Stage Kidney Disease Treatment Revenue Share by Type (2015-2020)
Figure 37. China End-Stage Kidney Disease Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 38. China End-Stage Kidney Disease Treatment Revenue Share by Application (2015-2020)
Figure 39. China End-Stage Kidney Disease Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. North America End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 43. North America End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 44. U.S. End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. U.S. End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Canada End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 49. Europe End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 51. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 52. Germany End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Germany End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. France End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. U.K. End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Region in 2019
Figure 65. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Region in 2019
Figure 66. China End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 91. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 92. Mexico End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa End-Stage Kidney Disease Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E End-Stage Kidney Disease Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E End-Stage Kidney Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. End-Stage Kidney Disease Treatment Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs